New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure

K Toljan, M Amin, A Kunchok, D Ontaneda - Journal of Neuroimmunology, 2022 - Elsevier
Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …
被引用次数：49 相关文章
[PDF] akw.sk

[PDF][PDF] New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure

K Toljan, M Amin, A Kunchok, D Ontaneda - Journal of Neuroimmunology, 2022 - akw.sk
Background: Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …

New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure.

K Toljan, M Amin, A Kunchok… - Journal of …, 2021 - europepmc.org
Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …

New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure

K Toljan, M Amin, A Kunchok… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …

New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure

K Toljan, M Amin, A Kunchok… - Journal of …, 2022 - jni-journal.com
Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …
[HTML] nih.gov

[HTML][HTML] New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure

K Toljan, M Amin, A Kunchok… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …

New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure.

K Toljan, M Amin, A Kunchok… - Journal of …, 2021 - europepmc.org
Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …